Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 2, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
AstraZeneca’s Triple Therapy BREZTRI Shows Promise in Phase III Asthma Trials
Life Sciences Times
-
May 2, 2025
Pharma
QPS India Successfully Completes Unscheduled US FDA Inspection, Reinforces Global Compliance Standards
Life Sciences Times
-
May 1, 2025
Pharma
Astria Therapeutics Publishes Promising Phase 1a Data on Navenibart in Leading Allergy Journal
Life Sciences Times
-
May 1, 2025
Pharma
Strand Therapeutics Unveils Promising Preclinical Data for STX-003, a Programmable mRNA Therapy Targeting Solid Tumors
Life Sciences Times
-
April 29, 2025
Pharma
Barth Syndrome Foundation Urges FDA to Act Swiftly on Delayed Elamipretide Decision
Life Sciences Times
-
April 29, 2025
Pharma
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH
Life Sciences Times
-
October 19, 2021
0
Pharma
U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy® for Treatment of HIV-1 in Pediatric Populations
Life Sciences Times
-
October 18, 2021
0
Pharma
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
Life Sciences Times
-
October 15, 2021
0
Pharma
Rhizen Pharmaceuticals AG Announces First Patient Dosing in a Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients
Life Sciences Times
-
October 14, 2021
0
Pharma
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug
Life Sciences Times
-
October 14, 2021
0
Pharma
VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, CONSTANT, of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine Candidate
Life Sciences Times
-
October 13, 2021
0
Pharma
COVID-19: Cytokine Storm and Coagulopathy Markers Controlled With Nichi Glucan Variants; The First of Its Kind Report in a Clinical Study
Life Sciences Times
-
October 12, 2021
0
Pharma
NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
Life Sciences Times
-
October 12, 2021
0
Pharma
Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® With Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Life Sciences Times
-
October 12, 2021
0
Pharma
Hunterian Medicine® Licenses Inscripta’s MAD7™ Nuclease to Advance Gene Editing Research and Development
Life Sciences Times
-
October 12, 2021
0
Pharma
RxCell Inc., A*STAR’s IMCB, NUS, and SERI Collaborate to Develop Cellular Therapeutics for Age-related Diseases
Life Sciences Times
-
October 11, 2021
0
Pharma
BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® for Treatment of Patients with Waldenström’s Macroglobulinemia
Life Sciences Times
-
October 8, 2021
0
1
...
43
44
45
...
63
Page 44 of 63
Most Read
Aktiia Raises $42 Million in Series B and Rebrands as Hilo to Expand Global Blood Pressure Monitoring
May 2, 2025
Virgo Unveils EndoML, a New AI Platform for Gastroenterology Research, at DDW 2025
May 2, 2025
Blue Cross Blue Shield of Massachusetts Offers Free $50 Bluebikes Credit for National Bike Month
May 2, 2025
Turn Therapeutics Achieves Breakthrough in Vaccine Stability, Opening Door to Cold-Chain-Free Delivery
May 2, 2025